Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
435 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07803081 | Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission(APROOB Cohort) | recruiting | — | 500 | Samsung Medical CenterOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT07772804 | Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation | not yet recruiting | N/A | 164 | Samsung Medical CenterOTHER | 1 | Aug 27, 2026 |
| NCT07774520 | A Randomized Study to Evaluate the Efficacy of a Reduced Starting Dose of Lazertinib (Leclaza) and Preemtive Magnesium Supplementation to Prevent Lazertinib(Leclaza)-Induced Peripheral Neuropathy | recruiting | Phase 2 | 1,173 | Samsung Medical CenterOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT02688894 | The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S] | recruiting | — | 797 | Samsung Medical CenterOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT03578185 | Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy(LC_Biomarker) | recruiting | — | 2,000 | Samsung Medical CenterOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07757958 | Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early Breast Cancer(APROOB) | not yet recruiting | Phase 3 | 520 | Samsung Medical CenterOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT05775757 | SMC Radiation Oncology Breast Cancer Cohort Study(RASCO) | active not recruiting | — | 500 | Samsung Medical CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT05893966 | Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer(BOOST-HER2) | recruiting | — | 400 | Samsung Medical CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07738250 | Routine LDL Exam For Cancer Survivors(LDL Cancer) | completed | — | 1,294,726 | Samsung Medical CenterOTHER | 0 | Jul 31, 2026 | clinicaltrials |
| NCT07688356 | Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors | recruiting | Phase 2 | 30 | Samsung Medical CenterOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT04536675 | Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery | active not recruiting | Phase 3 | 204 | Samsung Medical CenterOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT07646041 | Annual Brain MRI Surveillance for Detection of Brain Metastasis in Patients With Lung Cancer | completed | — | 229,323 | Samsung Medical CenterOTHER | 0 | Jun 12, 2026 | clinicaltrials |
| NCT04632459 | Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer | completed | Phase 2 | 26 | Samsung Medical CenterOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT07607119 | PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer | recruiting | N/A | 53 | Samsung Medical CenterOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT04591002 | Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive) | recruiting | Phase 2 | 43 | Samsung Medical CenterOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT05528458 | Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma | recruiting | Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT07300891 | T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy | not yet recruiting | Phase 2 | 72 | Samsung Medical CenterOTHER | 0 | Apr 28, 2026 | clinicaltrials |
| NCT05797545 | Comparison of Ultrasound and Breast MRI for Breast Cancer Detection | active not recruiting | N/A | 1,756 | Samsung Medical CenterOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT02546895 | Prospective Registration of Head and Neck Cancer | completed | — | 2,000 | Samsung Medical CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT05625893 | Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion | completed | Phase 2 | 63 | Samsung Medical CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT06552559 | Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma(SIENA) | recruiting | Phase 1 / Phase 2 | 37 | Samsung Medical CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT06330038 | Anesthesia and Non-small Cell Lung Cancer Recurrence(GASTIVA) | recruiting | Phase 4 | 5,384 | Samsung Medical CenterOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07500701 | Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer | recruiting | Phase 3 | 270 | Samsung Medical CenterOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07452432 | Korean Prospective Upper Tract Urothelial Carcinoma Cohort | recruiting | — | 300 | Samsung Medical CenterOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04568278 | Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatment. | completed | N/A | 222 | Samsung Medical CenterOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07439497 | Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer(DEHIM_CCRT) | recruiting | Phase 2 | 34 | Samsung Medical CenterOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT06922513 | Clinical Feasibility of Mobile App-Based Self-Management for Breast Cancer-Related Lymphedema | completed | N/A | 58 | Samsung Medical CenterOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07161479 | Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA) | recruiting | N/A | 160 | Samsung Medical CenterOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07381231 | Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors(I-APT) | recruiting | Phase 2 | 35 | Samsung Medical CenterOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07332156 | Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas | completed | — | 21,692 | Samsung Medical CenterOTHER | 0 | Jan 14, 2026 | clinicaltrials |
| NCT07309887 | This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer.(PRIORITY) | not yet recruiting | — | 100,000 | Samsung Medical CenterOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT06383884 | Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion | recruiting | Phase 2 | 30 | Samsung Medical CenterOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07269626 | PULSAR in Systemic Therapy for Pancreatic Cancer | recruiting | Phase 2 | 47 | Samsung Medical CenterOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07225374 | Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC | recruiting | Phase 2 | 48 | Samsung Medical CenterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT07211139 | Head and Neck Advanced Research for Multi-Omics and Optimized Immunotherapy(HARMONI) | recruiting | — | 30 | Samsung Medical CenterOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07201571 | A Retrospective Cohort Study of Patients Who Underwent Curative-intent Esophagectomy for ESCC at a Tertiary Referral Center in South Korea | completed | — | 3,131 | Samsung Medical CenterOTHER | 0 | Oct 1, 2025 | clinicaltrials |
| NCT07190573 | Head and Neck Cancer Omics/Integrated Precision Medicine (HOPE)(HOPE) | recruiting | — | 350 | Samsung Medical CenterOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT07173868 | FDG PET-CT in Advanced Breast Cancer(PET-000) | recruiting | — | 100 | Samsung Medical CenterOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT04665687 | Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients | recruiting | — | 1,730 | Samsung Medical CenterOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07165275 | Factors Associated With Health-related Quality of Life in Patients With Breast Cancer-Related Lymphedema Undergoing Prospective Surveillance | completed | — | 203 | Samsung Medical CenterOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT07121335 | SMC Radiation Oncology SABR Cohort for Oligometastasis(SABR-OMOP) | recruiting | — | 60 | Samsung Medical CenterOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT07092397 | Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer | completed | — | 266 | Samsung Medical CenterOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT07064655 | Non-gastric Conduit Reconstruction After Esophagectomy | not yet recruiting | — | 25 | Samsung Medical CenterOTHER | 0 | Jul 15, 2025 | clinicaltrials |
| NCT05896865 | Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer(RADAPT-N3) | recruiting | N/A | 120 | Samsung Medical CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT05907681 | Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M) | recruiting | — | 400 | Samsung Medical CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT05933733 | Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer(SALT-LRR) | recruiting | — | 190 | Samsung Medical CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT07028008 | Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors | not yet recruiting | N/A | 9 | Samsung Medical CenterOTHER | 0 | Jun 26, 2025 | clinicaltrials |
| NCT07032103 | Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV(SMCLYM-IV) | recruiting | — | 2,000 | Samsung Medical CenterOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT07024849 | Developing an Ecological and Tailored Nutritional Intervention to Improve Quality of Life in Esophageal Cancer Survivors | recruiting | N/A | 30 | Samsung Medical CenterOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07009600 | Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer | completed | — | 124 | Samsung Medical CenterOTHER | 0 | Jun 6, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials